Good management practices for oral anticoagulant overdose, situations of hemorrhagic risk and hemorrhagic events in patients taking oral anticoagulants in the ambulatory and hospital setting--April 2008
Sie, P.; Bouget, J.; Boulain, T.; Castot, A.; Dumarcet, N.; Druais, P-Louis.; Gruel, Y.; Helft, G.; Huas, D.; Iung, B.; Laroche, J-Pierre.; Leger, P.; Mahe, I.; Pavie, A.; Pelladeau, A.; Roy, P-Marie.; Samama, C-Marc.
Journal des Maladies Vasculaires 33(4-5): 202-213
2008
ISSN/ISBN: 0398-0499 PMID: 19143043 Document Number: 627638
Document emailed within 1 workday
Related Documents
Cervin, A.; Billström, R. 1992: Hemorrhagic complications of oral anticoagulants--who is affected and why? Lakartidningen 89(15): 1292-1294Lourenço, D.M.; Morelli, V.M.; Vignal, C.V. 1998: Treatment for overdose of oral anticoagulants Arquivos Brasileiros de Cardiologia 70(1): 9-13
Gianetti, J.; Gensini, G.; De Caterina, R. 1998: A cost-effectiveness analysis of aspirin versus oral anticoagulants after acute myocardial infarction in Italy -- equivalence of costs as a possible case for oral anticoagulants Thrombosis and Haemostasis 80(6): 887-893
Cosmi, B.; Palareti, G.; Moia, M.; Pengo, V.; Testa, S. 1999: Home use of an ambulatory monitor for the determination of prothrombin time (coaguchek) in patients treated with oral anticoagulants. Multicenter prospective study Minerva Cardioangiologica 47(12): 598-599
Tripodi, A.; Chantarangkul, V.; Clerici, M.; Mannucci, P.M. 2002: Laboratory diagnosis of lupus anticoagulants for patients on oral anticoagulant treatment. Performance of dilute Russell viper venom test and silica clotting time in comparison with Staclot LA Thrombosis and Haemostasis 88(4): 583-586
Mayurasakorn, S.; Suttipun, N. 2010: The impact of a program for strengthening dengue hemorrhagic fever case management on the clinical outcome of dengue hemorrhagic fever patients Southeast Asian Journal of Tropical Medicine and Public Health 41(4): 858-863
Abu-Zeitone, A.; Peterson, D.R.; Polonsky, B.; McNitt, S.; Moss, A.J. 2014: Oral contraceptive use and the risk of cardiac events in patients with long QT syndrome Heart Rhythm 11(7): 1170-1175
Pan, E.Y.; Sobieraj, D.M. 2016: Considerations for Prescribing Target-Specific Oral Anticoagulants in the Setting of Renal Dysfunction or Drug Interactions Connecticut Medicine 80(2): 105-111
Lozano, F.; Ramos, M.; Morán, M.; Almazán, A.; Ingelmo, A.; Gómez Alonso, A. 1984: Hemorrhagic complications of anticoagulants (heparin and dicoumarins) in the treatment of deep venous thrombosis. Report of 176 consecutive patients Angiologia 36(3): 118-120
Setiabudi, E.; Alwi, I.; Setiati, S. 2008: Oral anticoagulant treatment in management of elderly patients with atrial fibrillation [corrected]: is it beneficial or detrimental? Acta Medica Indonesiana 40(1): 40-47
Scarano, A.; Murmura, G.; Di Cerbo, A.; Palmieri, B.; Pinchi, V.; Mavriqi, L.; Varvara, G. 2013: Anti-hemorrhagic agents in oral and dental practice: an update International Journal of Immunopathology and Pharmacology 26(4): 847-854
Pan, E.; Tsai, J.S.; Mitchell, S.B. 2009: Retrospective study of venous thromboembolic and intracerebral hemorrhagic events in glioblastoma patients Anticancer Research 29(10): 4309-4313
Enocksson, E.; Jonsson, B. 1990: Hemorrhagic disease of the newborn. Several cases of late onset despite oral vitamin K prophylaxis Lakartidningen 87(22): 1944-1945
Engelke, C.; Bittscheidt, H.; Poley, F. 1995: Mesenteric vein thrombosis with hemorrhagic infarct of the small intestinal as a complication of oral contraceptives Der Chirurg; Zeitschrift für Alle Gebiete der Operativen Medizen 66(6): 634-637
Zotova, I.V.; Zateĭshchikov, D.A. 2011: Risk and benefit of oral anticoagulants in atrial fibrillation Kardiologiia 51(10): 81-91
Davidovich, I.M.; Sirotin, B.Z.; Parshina, T.A. 1999: Effects of sodium ethamsylate on anticoagulant and anti-aggregation activity of vascular endothelium in hemorrhagic fever patients with renal syndrome Terapevticheskii Arkhiv 71(6): 49-53
Pavlosky, M.; Carreras, L.O.; Lazzari, M.A.; Albertal, J. 1981: Hemorrhagic complications in anticoagulant therapy Medicina 41 Suppl: 274-277
Tripodi, A.; Cattaneo, M.; Molteni, A.; Cesana, B.M.; Mannucci, P.M. 1998: Changes of prothrombin fragment 1+2 (F 1+2) as a function of increasing intensity of oral anticoagulation--considerations on the suitability of F 1+2 to monitor oral anticoagulant treatment Thrombosis and Haemostasis 79(3): 571-573
Schöndorf, H. 1974: Hemorrhagic complications in the nervous system during anticoagulant therapy Münchener Medizinische Wochenschrift 116(8): 373-378
Franchi, M.; Mella, R.; Bortolini, S.; Calura, G. 1995: Hemostasis in patients at high hemorrhagic risk Minerva Stomatologica 44(5): 235-240